Email Updates

You are here

Home

5 MAY 2023 VOLUME 25 ISSUE 18

Media Coverage

  • Geographic Mobility Impacts Vulnerability to HIV Among Gay and Bisexual Latino Migrants to the US

    Gay and bisexual Latino migrants in the United States, especially but not only those who are undocumented, are vulnerable to higher rates of sexual risk behaviours and HIV transmission, a recent study published in Social Science and Medicine found. The study identified homophobia and HIV related stigma in their residential communities, barriers to well-paid work, access to affordable, appropriate healthcare, and isolation from the LGBTQ+ community as the main contributing factors for their increased vulnerability.

    May 5, 2023
    General
    aidsmap

  • Continuing the Quest After MOSAICO

    In 1984, former Health and Human Services Secretary Margaret Heckler declared there would be an HIV vaccine within two years. People are still waiting, and many thought that the announcement early this year by Janssen Pharmaceuticals that it was discontinuing the MOSAICO HIV vaccine trial was a death knell to the quest. Although the announcement was disappointing, experts at CROI 2023, held in Seattle, said the work on an HIV vaccine was not over. Several people are still working on the quest, and so there is still hope.

    May 5, 2023
    HIV Vaccine
    Infectious Disease Special Edition

  • Walensky To Resign as CDC Director

    Dr. Rochelle Walensky, the director of the Centers for Disease Control and Prevention, will step down from her position on June 30, she announced on Friday. In an agencywide meeting, Dr. Walensky admitted to having mixed emotions about her decision and broke down in tears, according to people on a conference call with her.

    May 5, 2023
    General
    New York Times

  • Five Men Appear to Have Acquired Mpox Twice

    One of my friends tested positive for mpox last summer during the peak of the outbreak. He had dozens of anal lesions that made going to the bathroom—and even sitting—excruciating. But overall, he described himself as lucky. The lesions were all on the outside of his body, he had few skin lesions, and his symptoms cleared in about six weeks.

    May 4, 2023
    General
    TheBody

  • Black Women Researchers Are Needed to Make PrEP Use More Equitable: Interview With Danielle Campbell, MPH

    While concluding her presentation, “Taking control over our bodies: Black women, sex, violence, and HIV,” at NMAC’s Biomedical HIV Prevention Summit in Las Vegas this past April, HIV prevention researcher and advocate Danielle Campbell, MPH, suddenly shared the words of freedom fighter Assata Shakur: “It is our duty to fight for our freedom. It is our duty to win. We must love each other and support each other. We have nothing to lose but our chains.” —Assata: An Autobiography

    May 4, 2023
    PrEP
    TheBody

  • Courageous LGBTQ+ Minority in India Defies HIV Stigma With PrEP

    Every morning, Neharika Ravalkar takes a pill that stops her joining the millions of Indians who are HIV positive. As a trans woman, Ravalkar is among the groups at highest risk of HIV. But she is among a lucky minority taking pre-exposure prophylaxis (PrEP) medication as cost, lack of awareness and stigma all hamper access in the South Asian nation.

    May 4, 2023
    PrEP
    Business Live

  • Combination CRISPR, Antiretroviral Therapies Could Eliminate 100 Percent of HIV

    Combining 2 clustered regularly interspaced short palindromic repeats (CRISPR) gene editing therapies with antiretroviral therapy (ART) effectively eliminated human immunodeficiency virus type 1 (HIV-1) in humanized and infected mice, according to the results of a study published in PNAS. The dual CRISPR technology has 2 targets: The HIV-1 virus’s C-C chemokine receptor type 5 (CCR5) coreceptor, which enables HIV-1 entry into the cell; and the HIV-1 long terminal repeat (LTR)-Gag region of infected cells, which contains dormant viral DNA.

    May 4, 2023
    Treatment
    Pharmacy Times

  • CAB-LA Game Changer for Closing the Leaks to New HIV Infections Among Young People

    Zimbabwe approved cabotegravir long-acting (CAB-LA) for HIV prevention. In March 2021, the Medicines Control Authority of Zimbabwe (MCAZ) approved CAB-LA for use as HIV pre-exposure prophylaxis (PrEP) in combination with oral emtricitabine/tenofovir disoproxil fumarate (FTC/TDF). This landmark approval made Zimbabwe the second country in sub-Saharan Africa, after South Africa, to approve CAB-LA for HIV prevention.

    May 3, 2023
    PrEP
    Health Times

  • One Dose of HPV Vaccine Prevents Infection for at Least Three Years

    A single dose of the human papillomavirus vaccine is highly effective at preventing infections over three years, most likely lowering rates of cervical cancer and other diseases linked to the virus, according to a new study in Kenya. A single-dose strategy would dramatically extend supplies of the vaccine, lower costs and simplify distribution, which would make vaccination a more viable option in countries with limited resources, experts said.

    May 2, 2023
    HPV Vaccines
    New York Times

  • Does HIV Status Affect Tecovirimat Treatment Efficacy in Mpox Patients?

    In May 2022, outbreaks of the mpox virus (formerly called monkeypox) in nonendemic countries placed the world on high alert. Mpox is a zoonotic Orthopox virus, similar to smallpox. The most infamous mpox symptoms is a fluid-filled, blister-like rash that can be very itchy or painful.

    May 2, 2023
    General
    Contagion Live

  • A Battle Between Gilead and the US Government Over Patents on HIV Prevention Pills Goes to Trial

    After years of sparring, the federal government and Gilead Sciences will square off in a Delaware courtroom this week in a bid to settle dueling claims over the rights to a pair of groundbreaking and lucrative HIV prevention pills. The case has drawn attention because a central theme is the extent to which taxpayer-funded research may be used by a pharmaceutical company to reap enormous profits, and whether the prices charged for any resulting medicine are out of reach for many Americans.

    May 2, 2023
    PrEP
    STAT

  • Gilead, US Square Off in Billion-Dollar HIV Drug Patent Trial

    Gilead Sciences Inc (GILD.O) is headed to trial in Delaware federal court this week to fight claims that it owes the US government a share of multibillion-dollar profits from its HIV-prevention drug regimen. The government is seeking more than $1 billion from Gilead for allegedly failing to compensate the Centers for Disease Control and Prevention (CDC) for discovering that Gilead's HIV-treatment drug Truvada could help prevent the disease.

    May 2, 2023
    PrEP
    Reuters

  • Advocate Ruele Okeyo: I Was 23 When I Tested HIV Positive

    Ruele Okeyo has been a sensation on social media after videos of him recording himself taking HIV drugs went viral. Silas Nyamweya followed him to find out his motivation and how he deals with online trolls.

    May 2, 2023
    General
    Standard Media

  • Herpes Study Adds to Understanding of Viral Reinfections, Including How To Potentially Prevent Them

    A new study on herpes infections of the eye from University of Illinois Chicago researchers helps shed light on the question of viral reinfections by identifying a key protein involved in viral reinfections that could be targeted by antiviral drugs. The UIC team examined how the heparanase protein, which is present in all our cells, affects reinfection from the herpes simplex virus type 1 in mice.

    May 1, 2023
    General
    Medical Xpress

  • Why Tanzania Should Consider New Options for HIV Prevention

    Tanzania has only seven years left to reach the UNAIDS 95-95-95 targets to end the HIV/AIDS epidemic by 2030. The target aims to have 95 percent of people living with HIV diagnosed, 95 percent of those diagnosed on antiretroviral therapy (ART) and 95 percent of those on ART with suppressed viral loads.

    May 1, 2023
    General
    The Citizen

  • Biden to Tap Monica Bertagnolli as Director of National Institutes of Health

    According to multiple news reports, President Biden has nominated Monica M. Bertagnolli, MD, to serve as the Director of the National Institutes of Health (NIH). This role is critical to ensuring ongoing innovation in medical research, including in oncology, and Bertagnolli could not be a better choice to lead the NIH into the bold future. In addition to previously holding many professional memberships and appointments, Bertagnolli also served on the American Cancer Society (ACS)’s Board of Directors.

    May 1, 2023
    General
    POZ Magazine

  • California Man Known as ‘City of Hope Patient’ Comes Forward, 1 of 5 Cured of HIV Worldwide

    For the past two years, Paul Edmonds has been part of an extremely exclusive club with a membership that has reached five people. After navigating HIV for more than 30 years, along with a leukemia diagnosis that came in 2018, a life-saving stem cell transplant became available thanks to a donor who had a rare genetic mutation that makes the body resistant to most strains of HIV. In 2021, Edmonds stopped taking his HIV medication, which he had been dependent on for almost half his life.

    April 30, 2023
    Cure
    USA Today

  • US Postpones Uganda Meeting on HIV Protection Scheme After Anti-LGBTQ+ Bill Passes

    US officials have postponed a meeting on setting up a HIV protection scheme in Uganda to assess the damage that the country’s anti-LGBTQ+ bill will have on the program. A US State Department spokesperson told Uganda officials on Tuesday (25 April) that it needed time to consider the ramifications of the bill before it could continue talks on the US president’s Emergency Plan For AIDS Relief (PEPFAR).

    April 30, 2023
    General
    PinkNews

  • Rwamagana: Youth Encouraged to Circumcise, Test for HIV

    In an effort to promote safe sex practices and reduce the spread of HIV, Rwamagana officials are encouraging young people in the district to undergo circumcision and self-HIV testing. This proactive approach aims to provide accessible resources and education to youth, ultimately improving their sexual health and well-being. According to Jeanne Umutoni, the Vice Mayor of Rwamagana District in charge of Social Affairs, free circumcision services are offered at health centers throughout the district.

    April 29, 2023
    Voluntary Medical Male Circumcision
    New Times

  • Reframing HPV Shot as Cancer Vaccine Improved Uptake Among 9-Year-Olds

    Experts at the Pediatric Academic Societies Meeting suggested reframing conversations about HPV to encourage parents to get children vaccinated starting at age 9 years. Recently, researchers reported that moving HPV vaccine initiation to age 9 or 10 years could improve coverage. Although the rate of teenagers being vaccinated has improved in recent years, parents still remain hesitant about HPV vaccination.

    April 29, 2023
    HPV Vaccines
    Healio

Published Research

Announcements